Position in BHC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$117,505
-$688,509 QoQ
Shares Held
23,835
-84.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#142
of 220 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Derivatives in BHC
reported options exposure · as of Sep 30, 2020CallValue
$582,750
CallShares
37,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. BHC ranks #43 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,278 | $130,014,715 | |
| 2 | HLN |
Haleon plc
|
4,924,330 | $45,943,997 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
253,026 | $42,644,999 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
74,303 | $40,259,592 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
976,361 | $24,028,242 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
559,389 | $19,394,014 | |
| 7 | VTRS |
Viatris Inc
|
1,175,495 | $18,666,859 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,150,820 | $18,447,643 |
All Filings in BHC
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $117,505 | 23,835 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $806,014 | 149,262 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,358,224 | 339,313 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,982,200 | 307,318 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,417,359 | 212,817 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,139,609 | 330,697 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $208,809 | 25,907 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $195,929 | 24,011 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $215,254 | 30,883 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $265,218 | 24,997 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,624,498 | 202,556 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $249,402 | 30,341 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $269,840 | 33,730 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $289,905 | 35,791 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $457,491 | 72,849 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $295,194 | 42,844 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,081,033 | 488,162 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $11,145,726 | 487,778 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,878,034 | 538,864 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $15,971,027 | 573,466 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,410,767 | 525,606 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $31,780,468 | 1,001,275 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $21,318,606 | 1,024,933 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $582,750 | 37,500 | Call | Defined | 2020-11-05 | |
| 2020-09-30 | $19,955,783 | 1,284,156 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $16,947,440 | 926,596 | Shares | Defined | 2020-08-13 | |
| 2020-06-30 | $31,000 | 37,500 | Call | Defined | 2020-08-13 | |
| 2020-03-31 | $4,165,392 | 268,735 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||